These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19064562)

  • 1. Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.
    Chen C; Sakoda LC; Doherty JA; Loomis MM; Fish S; Ray RM; Lin MG; Fan W; Zhao LP; Gao DL; Stalsberg H; Feng Z; Thomas DB
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3457-66. PubMed ID: 19064562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women.
    Sakoda LC; Blackston CR; Doherty JA; Ray RM; Lin MG; Gao DL; Stalsberg H; Feng Z; Thomas DB; Chen C
    Cancer Epidemiol; 2011 Feb; 35(1):48-55. PubMed ID: 20846920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women.
    Sakoda LC; Blackston C; Doherty JA; Ray RM; Lin MG; Stalsberg H; Gao DL; Feng Z; Thomas DB; Chen C
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1066-73. PubMed ID: 18483327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.
    Long JR; Kataoka N; Shu XO; Wen W; Gao YT; Cai Q; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2115-22. PubMed ID: 17119036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione S-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese women.
    Sakoda LC; Blackston CR; Xue K; Doherty JA; Ray RM; Lin MG; Stalsberg H; Gao DL; Feng Z; Thomas DB; Chen C
    Breast Cancer Res Treat; 2008 May; 109(1):143-55. PubMed ID: 17624589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study.
    Cai Q; Kataoka N; Li C; Wen W; Smith JR; Gao YT; Shu XO; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):27-32. PubMed ID: 18199708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CYP19A1 single-nucleotide polymorphism with digit ratio (2D:4D) in a sample of men and women from Ningxia (China).
    Zhanbing M; Jie D; Chunyue B; Hong L; Liang P; Zhenghao H
    Early Hum Dev; 2019 May; 132():58-65. PubMed ID: 30986648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China.
    Li W; Ray RM; Lampe JW; Lin MG; Gao DL; Wu C; Nelson ZC; Fitzgibbons ED; Horner N; Hu YW; Shannon J; Satia JA; Patterson RE; Stalsberg H; Thomas DB
    Int J Cancer; 2005 Jul; 115(6):981-93. PubMed ID: 15723298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China.
    Shannon J; King IB; Lampe JW; Gao DL; Ray RM; Lin MG; Stalsberg H; Thomas DB
    Am J Clin Nutr; 2009 Jan; 89(1):265-76. PubMed ID: 19056601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
    Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
    Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China.
    Atkinson C; Ray RM; Li W; Lin MG; Gao DL; Shannon J; Stalsberg H; Porter PL; Frankenfeld CL; Wähälä K; Thomas DB; Lampe JW
    Nutr Res; 2016 Aug; 36(8):863-71. PubMed ID: 27440541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study.
    Boone SD; Baumgartner KB; Baumgartner RN; Connor AE; Pinkston CM; Rai SN; Riley EC; Hines LM; Giuliano AR; John EM; Stern MC; Torres-Mejía G; Wolff RK; Slattery ML
    Cancer Causes Control; 2014 Nov; 25(11):1461-71. PubMed ID: 25088806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between rs10046, rs1143704, rs767199, rs727479, rs1065778, rs1062033, rs1008805, and rs700519 polymorphisms in aromatase (CYP19A1) gene and Alzheimer's disease risk: a systematic review and meta-analysis involving 11,051 subjects.
    Song Y; Lu Y; Liang Z; Yang Y; Liu X
    Neurol Sci; 2019 Dec; 40(12):2515-2527. PubMed ID: 31278540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China.
    Lampe JW; Nishino Y; Ray RM; Wu C; Li W; Lin MG; Gao DL; Hu Y; Shannon J; Stalsberg H; Porter PL; Frankenfeld CL; Wähälä K; Thomas DB
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2579-86. PubMed ID: 18086761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled trial.
    Kopp TI; Jensen DM; Ravn-Haren G; Cohen A; Sommer HM; Dragsted LO; Tjonneland A; Hougaard DM; Vogel U
    BMC Cancer; 2016 Apr; 16():283. PubMed ID: 27102200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of aromatase gene (CYP19A1) in essential hypertension.
    Shimodaira M; Nakayama T; Sato N; Saito K; Morita A; Sato I; Takahashi T; Soma M; Izumi Y
    Int J Med Sci; 2008 Feb; 5(1):29-35. PubMed ID: 18274619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
    Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive association of polymorphisms in estrogen biosynthesis gene, CYP19A1, and metabolism, GST, in breast cancer susceptibility.
    Ramalhinho AC; Fonseca-Moutinho JA; Breitenfeld Granadeiro LA
    DNA Cell Biol; 2012 Jun; 31(6):1100-6. PubMed ID: 22300440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.
    Tao MH; Cai Q; Zhang ZF; Xu WH; Kataoka N; Wen W; Xiang YB; Zheng W; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):943-9. PubMed ID: 17507620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of CYP19A1 gene rs7176005 single nucleotide polymorphism with breast cancer risk and clinicopathologic features of tumor].
    Du ZG; Wang LY; Zhou Y; Wan HY; Liang FQ; Lyu Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Aug; 52(8):827-832. PubMed ID: 30107717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.